Peter Talbot

Overview

Associate Director, Wolfson Molecular Imaging Centre

Senior Lecturer in Molecular Neuroimaging

Editorial Advisory Board, Journal of Psychopharmacology

Vice Chair, Medicines Management Committee, Manchester Mental Health & Social Care Trust

Honorary General Secretary (2017-2022), British Association for Psychopharmacology

President-elect, Manchester Medical Society Psychiatry Division

Biography

Peter Talbot qualified in Medicine from the University of Bristol, and completed his specialist clinical training and MD in Psychiatry in his native Northern Ireland. His postdoctoral research training was in Positron Emission Tomography (PET) neuroimaging under the supervision of Marc Laruelle at Columbia University in New York, followed by appointment as Assistant Professor in Psychiatry there in 2004. He joined the University of Manchester in 2005, where he is Senior Lecturer in Molecular Neuroimaging and Associate Director of the Wolfson Molecular Imaging Centre. His research interest is the use of PET to investigate abnormal brain mechanisms in severe mental illness, particularly psychosis, affective disorders and impulsivity. He is active in neuroscience and psychopharmacology teaching both locally (Lead for undergraduate and postgraduate modules; Chair of the Affective Disorders Group North West) and nationally for the BAP (Course Organiser for the Schizophrenia Module; lecturer on the Affective Disorders Module and Depression Masterclass).

In his clinical work he is Honorary Consultant Psychiatrist with Manchester Mental Health and Social Care Trust and Director of the Specialist Service for Affective Disorders, a regional tertiary-level NHS clinic.